Advertisement Welichem names new president and CEO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Welichem names new president and CEO

Welichem Biotech has appointed Genhui Chen as president and CEO of the company, effective immediately.

A long time director and one of the founders of the company, Mr Chen is expected to guide Welichem Biotech through the next crucial stage of development as the company realizes the potential value of its drug candidates in clinical trials.

York Yingping Guo resigned as president and CEO for personal and family reasons.

John Webster, interim chairman of Welichem, said: “Mr Chen has a deep understanding of both the business and scientific components of the company and related international experience in the biotech industry. His commitment and insight will be invaluable.”